Individuals have used marijuana, also known as cannabis, for a number of health conditions for at least 3,000 decades. More recently, human elements of bud or comparable synthetic substances also have been used for health purposes. These substances are known as cannabinoids.
But some states and the District of Columbia permit its use for specific health functions. Whether marijuana has therapeutic advantages that outweigh its health dangers is unclear.
In 2018, the bureau accepted Epidiolex oral solution for the treatment of seizures related to two uncommon, severe forms of epilepsy. You can also browse online resources to buy clones for sale los angeles.
This medication comes from marijuana. The FDA has also accepted the synthetic cannabinoids dronabinol and nabilone to deal with nausea and vomiting associated with cancer in those who have taken other medications to treat those symptoms with no great outcomes.
Dronabinol includes artificial delta-9-tetrahydrocannabinol (THC), a part of marijuana, and nabilone includes a synthetic compound with an identical chemical structure. In 2016, the FDA accepted Syndrome, a liquid type of dronabinol.
The FDA has decided it is not legal to market products which contain THC or CBD as dietary supplements. It's also not authorized to market foods including additional THC or CBD in interstate trade.
The report summarizes the current evidence on both curative results and damaging consequences, urges that research has been performed in order to develop an extensive understanding of the health effects of marijuana, also urges that measures be taken to overcome regulatory hurdles that will make it hard to do research on marijuana's health effects.